NewsRoom Articles - Page 105 of 154 - PsychedelicNewsWire (PNW)

ThursdayMar 04, 2021 2:45 pm

Why Companies Should Manufacture Psychedelic Pharmaceuticals on Large Scale

The development of a new class of pharmaceutical medications made from psychedelic fungi and plants has brought medical science closer to making breakthroughs that address the global mental health crisis caused by the pandemic. These drugs have shown massive potential in the treatment of chronic depression. However, there are challenges that come with the development of standardized organic compounds to help treat more than a billion individuals globally for various mental health conditions. Frankly speaking, it’s complicated and costly to separate active ingredients in multi-compound organic substances. Globally, this has not been done on a broad scale anywhere, primarily for…

ThursdayMar 04, 2021 12:12 pm

Cybin Inc. (NEO: CYBN) (OTC: CLXPF) Newly Acquired Subsidiary Achieves Earn-Out Milestone —Successful Synthesis of Multiple Tryptamine Derivatives

Adelia Therapeutics has achieved earn-out milestones outlined in contribution agreement with Cybin Adelia ideal acquisition for Cybin, as it leads innovation in researching psychedelic treatment options in the mental health space Acquisition results in Cybin obtaining extensive intellectual property portfolio and product pipeline Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, has announced that its recently acquired subsidiary, Adelia Therapeutics Inc., has achieved the earn-out milestones outlined for the time period in the contribution agreement between the two companies (https://ibn.fm/c6o2E). That milestone includes the successful synthesis of multiple tryptamine derivatives.…

WednesdayMar 03, 2021 1:00 pm

NYU Langone Health Sets Up Research Center for Psychedelic Medicine

Charitable donations and support valued at more than $10 million are aiding in the progression of NYU Langone Health’s study of psychedelic medicine. Langone Health will be launching a center for psychedelic medicine, which will focus on physician training and research in this burgeoning field. Once completed, the NYU Langone Center for Psychedelic Medicine, which will be under the Department of Psychiatry at NYU Langone, will center on a trio of transdisciplinary areas: preclinical, medicine and psychiatry research. In addition to this, the center will launch a Psychedelic Medicine Research Training Program, which will assist in the development of postdoctoral…

TuesdayMar 02, 2021 11:45 am

First Ever Psychedelic Therapy Clinic Launched in Calgary

Last week, the first psychedelic therapy clinic in the province launched in Calgary. The clinic is located in northwest Calgary and will be used as a mental health professional training center. Dr. Ravinder Bains, who is the facility’s chief medical officer, will be overseeing the psychedelic therapy. In an interview, David Harder, CEO of the ATMA Urban Journey Clinic, stated that the clinic was the result of years of a lot of studies and research. He noted that psychedelics did not work in the same way that standard psychotic medications or antidepressants worked. Harder explained that while conventional medications prescribed…

MondayMar 01, 2021 1:45 pm

Vermont Legislators Draft Drug, Psychedelic Decriminalization Bills for 2021 Session

Legislators in Vermont are planning to introduce no fewer than two measures to decriminalize drug possession this legislative session. In an interview, State Rep. Brian Cina stated that the bill he plans to introduce would eliminate penalties imposed on a range of fungi and plant-based psychedelics, including DMT, psilocybin, ibogaine and mescaline. In a press conference, Rep. Selene Colburn stated that a bill she was working on would decriminalize all drugs was being drafted and would be introduced later in the session. Colburn stated that legislators were still working out the model, adding that they would probably use Oregon’s measure…

FridayFeb 26, 2021 12:15 pm

California State Senator Introduces Bill to Decriminalize Psychedelics

Recently, a legislator from California introduced a bill that would decriminalize psychedelics in the state, in an attempt to end the disproportionate war on drugs that has raged in the country since the 1970s. The legislator who drafted the bill, Scott Weiner, hopes that by following in the footsteps of cities that have decriminalized psychedelics, such as the District of Columbia, Santa Cruz and Oakland, the state of California will be one step closer to decriminalizing both the possession and use of all drugs, which is what the state of Oregon did when it passed a similar ballot measure during…

ThursdayFeb 25, 2021 2:45 pm

Massachusetts Legislators Introduce Bills to Study Psychedelics, Remove Criminal Penalties

Last week, legislators in Massachusetts introduced initiatives that may help end the war on drugs in the state. One measure would establish a task force whose focus will be to study fungi and plant-based psychedelics, its objective being to regulate and legalize these substances. The second other proposal would do away with criminal penalties for drug possession. This isn’t the only call to end criminal prohibition in the state. Recently, the city councils of Cambridge and Somerville adopted initiatives that made possession of psychedelics among the lowest law enforcement priorities for their municipalities. HD 3439, which was introduced to the…

ThursdayFeb 25, 2021 12:27 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Inks First CBD Oil Commercial Sale; Looks to Grow in Key Spaces

Pure Extracts is preparing to deliver shipment of 85% pure CBD distillate Company proud of quality offering produced in world-class facility PULL uses proprietary state-of-the art, sub-critical/super-critical CO2extraction system Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company, has signed a contract for its first CBD oil commercial sale on the wholesale market (https://ibn.fm/92kPG). Pure Extracts is preparing to deliver the first of what it anticipates will be multiple shipments this year of its 85% pure CBD distillate under this contract. “We are excited to have completed our first commercial order, and we are proud of the quality of…

WednesdayFeb 24, 2021 3:02 pm

Will the Biden Administration Embrace Federal Psychedelic Reform?

President Joe Biden’s administration and Congress is underway, and while psychedelic reform isn’t among the administration’s top priorities, advocates are hopeful that the president’s term will bring more policy changes that will gradually do away with the federal prohibition of MDMA, psilocybin and other psychedelics. In the recent past, advocates of reform have mainly been focusing on local measures. During the November 2020 election, Washington, DC, decriminalized all fungi and plant-based psychedelics while the state of Oregon decriminalized all drugs and legalized psilocybin therapy. Since then, State Representative Michael Greico of Florida has been working on a measure to legalize…

TuesdayFeb 23, 2021 12:15 pm

Researchers to Investigate Whether DMT Can Accelerate Recovery from Stroke

Algernon Pharmaceuticals, a Canadian company, plans to conduct a clinical trial to study how DMT, a psychedelic drug, can be used to trigger faster recovery in people who have had a stroke. The company says that study participants will receive a “microdose,” or an amount too small to trigger the hallucinogenic effects of the drug. While this small dose is too small for subjects to “trip,” it is hoped that the small dose will be sufficient to boost the recovery of neural activity and connections within the brain, thereby reducing how much damage the brain could suffer during and after…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000